Site Members can sign up for company wide alerts
Investigation Overview
An investigation on behalf of investors of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares over potential securities laws violations by Brainstorm Cell Therapeutics Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of ...
You must register (for free) or login to view the entire investigation.